Strand Life Sciences And Pharmidex To Collaborate To Produce A New In Silico Technology For CNS Drug Discovery

Strand Life Sciences, the premier in silico technologies innovation company announced today that it has entered into collaboration with Pharmidex, a world leader in assessing the ability of compounds to cross the blood-brain barrier (BBB).

Back to news